Yokogawa Insilico Biotechnology Named Winner of 2022 Pharma Innovation Award

Originally Published in Pharma Manufacturing Magazine - Pharma Innovation Awards


Winning Technologies for a Bright Pharma Future

Our first winner leverages artificial intelligence and mechanistic knowledge to enable cell culture performance prediction. Yokogawa Insilico Biotechnology released its Insilico Digital Twin Factory, which can help drugmakers increase productivity and bring down manufacturing costs and time to market by potentially replacing up to 50% of the experiments needed during the process development, characterization and scale-up of biopharmaceuticals.

The digital twins use an advanced hybrid blueprint formed from a mechanistic model of the unique characteristics of an intracellular metabolic network and a data-driven model to allow for the constant prediction of elements such as the soft sensing of substance components that cannot be measured directly, or the early detection of process abnormalities. 




Last year, Yokogawa Insilico released its “Insilico Advisor,” to help improve the efficiency of biologics manufacturing by providing for model predictive monitoring of the cell culture process.

Another significant development challenge facing the industry is poor solubility, especially when it comes to antibody-drug conjugates (ADCs). This emerging class of medicines — designed to target and destroy cancer cells while preserving healthy cells — can fail in the clinic due to poor aqueous solubility.





  • Pharmaceutical

    The pharmaceutical industry currently faces a major challenge in taking full advantage of the opportunities presented in large emerging markets. Now, more than ever, pharmaceutical companies need to introduce lean manufacturing techniques that will enhance profitability. As one of the world's leading industrial automation suppliers, Yokogawa is committed to delivering the best possible solutions for your best manufacturing practices.

    See More

Have Questions?

Contact a Yokogawa Expert to learn how we can help you solve your challenges.